Incorporating point-of-care technologies to assess treatment response in sickle cell disease
Authors:
- Bindu Parachalil GopalanBGBindu Parachalil Gopalan
- Timothy QuangTQTimothy Quang
- Maria A. Lizarralde-IragorriMLMaria A. Lizarralde-Iragorri
- Dianna LovinsDLDianna Lovins
- Ann CullinaneACAnn Cullinane
- Alina Dulau-FloreaADAlina Dulau-Florea
- Bruce TrombergBTBruce Tromberg
- Arun S. ShetASArun S. Shet
Open Access
- 21 May 2024
- journal article
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 1 (2)
Abstract
No abstract availableFunding Information
- National Institutes of Health (NCT05604547)
- National Heart, Lung, and Blood Institute (ZIA#HL006256, HL006241)
This publication has 7 references indexed in Scilit:
- Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trialBlood Advances, 2023
- The multifaceted role of ischemia/reperfusion in sickle cell anemiaJournal of Clinical Investigation, 2020
- The utility of thromboelastography and thrombin generation in assessing the prothrombotic state of adults with sickle cell diseaseThrombosis Research, 2017
- Combined multi-distance frequency domain and diffuse correlation spectroscopy system with simultaneous data acquisition and real-time analysisBiomedical Optics Express, 2017
- Treating sickle cell disease by targeting HbS polymerizationBlood, 2017
- Diffuse correlation spectroscopy for non-invasive, micro-vascular cerebral blood flow measurementNeuroImage, 2014
- Direct measurement of tissue blood flow and metabolism with diffuse opticsPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2011